Sanofi Drug for Heart Rhythm Disorder Is Approved
Friday, July 3, 2009 - 00:35
in Health & Medicine
Sanofi plans to begin marketing Multaq, generically known as dronedarone, in the United States this summer.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Heating heart with catheter better than drugs for common heart rhythm disorderThu, 14 May 2009, 11:16:11 EDT
- Heating heart with catheter works better than drugs for heart rhythm disorderWed, 12 Nov 2008, 13:18:11 EST
- Faster, better diagnosis for patients with heart rhythm disordersWed, 25 Mar 2009, 11:55:33 EDT
- Study makes first connection between heart disorder and Alzheimer's diseaseFri, 15 May 2009, 6:36:18 EDT
- Mount Sinai first with new technique to prevent a major cause for heart-related strokeFri, 21 Aug 2009, 17:31:25 EDT